These 9 biotech stocks have doubled this year and are set to double again, analysts say

  • 📰 CNBC
  • ⏱ Reading Time:
  • 24 sec. here
  • 11 min. at publisher
  • 📊 Quality Score:
  • News: 44%
  • Publisher: 72%

Jasper Therapeutics Inc Nyheter

Praxis Precision Medicines Inc,Corbus Pharmaceuticals Holdings Inc,Rezolute Inc

The bio tech stocks have on average risen by 188% this year and have a median upside potential of 150%.

Nine health-care stocks have more than doubled in price this year, but still have more than 100% upside potential, according to analysts.

Pro screened more than 85,000 firms worldwide for stocks that have risen by 100% so far in 2024. They are all covered by at least five or more analysts, and a have a median price target pointing to more than 100% upside potential over the next 12 months. The Nasdaq-listed stocks are Jasper Therapeutics , Corbus Pharmaceuticals , Rezolute , Trevi Therapeutics , Delcath Systems , Benitec Biopharma , Arcutis Biotherapeutics , Praxis Precision Medicines and Humacyte .

Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 12. in SE
 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.

Sverige Senaste nytt, Sverige Rubriker